Electrocore (ECOR) 2025 Earnings: Key Takeaways for Investors
Electrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
Biotech insights await. This page curates 5 articles on Tempus, Moderna, Praxis, ImmunityBio and market moves to help you evaluate stocks and sharpen your portfolio strategy.
58 articlesElectrocore (ECOR) is navigating a pivotal year. This article dives into the 2025 earnings landscape, unpacking reven...
A venture-backed biotech startup unveils a plan to collect genomic data from 100 million species to fuel AI drug disc...
New heart health guidelines urge Lp(a) testing for at-risk adults, sending demand for diagnostics higher. This report...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
A Sydney-based tech founder uses AI to design a bespoke cancer vaccine for his dog, Rosie, signaling a new frontier i...
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
What Mineralys (MLYS) reported in its 2025 earnings reveals more than numbers. This guide breaks down the quarter, th...
An almost 12% jump in lantheus holdings stock popped last month left investors asking what lit the fuse. This article...
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...